4.7 Article

External validation of three prognostic scores for brain metastasis velocity in patients treated with intracranial stereotactic radiotherapy

Related references

Note: Only part of the references are listed.
Article Oncology

Treatment for Brain Metastases: ASCO-SNO-ASTRO Guideline

Michael A. Vogelbaum et al.

Summary: The purpose of this study is to provide guidelines for clinicians on treating patients with brain metastases from solid tumors. The study conducted a systematic review of the literature and found that surgery is a reasonable option for patients with brain metastases. Local therapy should be given to patients with symptomatic brain metastases, regardless of the systemic therapy used. For patients with asymptomatic brain metastases, local therapy should not be deferred unless specifically recommended. Several regimens were recommended for different types of cancer. For patients with no systemic therapy options, stereotactic radiosurgery (SRS) alone should be offered. Memantine and hippocampal avoidance should be considered for patients receiving whole brain radiation therapy. Patients with low Karnofsky Performance Status and no systemic therapy options do not benefit from radiation therapy.

JOURNAL OF CLINICAL ONCOLOGY (2022)

Article Oncology

Comprehensive summary and retrospective evaluation of prognostic scores for patients with newly diagnosed brain metastases treated with upfront radiosurgery in a modern patient collective

Johannes Kraft et al.

Summary: This study compared different prognostic scores for patients with brain metastases and found that scores based on both clinical and laboratory parameters performed well in predicting survival. Performance status, systemic disease status, and laboratory parameters were significantly associated with overall survival.

RADIOTHERAPY AND ONCOLOGY (2022)

Article Oncology

Recent Trends in Synchronous Brain Metastasis Incidence and Mortality in the United States: Ten-Year Multicenter Experience

Wenqiang Che et al.

Summary: This study provides a comprehensive understanding of the changes in the incidence and mortality of synchronous brain metastases (SBMs) over the past ten years. It reveals a significant decrease in SBMs incidence and incidence-based mortality, with lung cancer, melanoma, and breast cancer being the most common primary cancer types.

CURRENT ONCOLOGY (2022)

Article Oncology

Epidemiology of brain metastases and leptomeningeal disease

Nayan Lamba et al.

Summary: Brain metastases significantly impact patients with advanced extracranial malignancies, but their incidence remains poorly described. Recent studies have shown the viability of using claims data for epidemiologic investigations of brain metastases.

NEURO-ONCOLOGY (2021)

Article Clinical Neurology

RADIOSURGERY FOLLOWED BY PLANNED OBSERVATION IN PATIENTS WITH ONE TO THREE BRAIN METASTASES

Johannes Lutterbach et al.

NEUROSURGERY (2008)